Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

DOG1: a novel marker of salivary acinar and intercalated duct differentiation.

Chênevert J, Duvvuri U, Chiosea S, Dacic S, Cieply K, Kim J, Shiwarski D, Seethala RR.

Mod Pathol. 2012 Jul;25(7):919-29. doi: 10.1038/modpathol.2012.57. Epub 2012 Mar 30.

2.

Bone morphogenetic protein-6 is a marker of serous acinar cell differentiation in normal and neoplastic human salivary gland.

Heikinheimo KA, Laine MA, Ritvos OV, Voutilainen RJ, Hogan BL, Leivo IV.

Cancer Res. 1999 Nov 15;59(22):5815-21. Erratum in: Cancer Res 2000 Jul 1;60(13):3668. Heikinheimo AK [corrected to Heikinheimo KA].

3.

Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas.

Abd Raboh NM, Hakim SA.

Int J Clin Exp Pathol. 2015 Aug 1;8(8):9214-22. eCollection 2015.

4.

SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis.

Ohtomo R, Mori T, Shibata S, Tsuta K, Maeshima AM, Akazawa C, Watabe Y, Honda K, Yamada T, Yoshimoto S, Asai M, Okano H, Kanai Y, Tsuda H.

Mod Pathol. 2013 Aug;26(8):1041-50. doi: 10.1038/modpathol.2013.54. Epub 2013 Apr 5.

5.

Lysozyme Expression Can be Useful to Distinguish Mammary Analog Secretory Carcinoma from Acinic Cell Carcinoma of Salivary Glands.

Mariano FV, Gómez CA, de Souza do Nascimento J, Dos Santos HT, Egal ES, Montalli VA, Vargas PA, de Almeida OP, Altemani A.

Head Neck Pathol. 2016 Dec;10(4):429-436. Epub 2016 May 13.

6.

MUC1 and MUC2 expression in salivary gland tumors and in non-neoplastic salivary gland tissue.

Mannweiler S, Beham A, Langner C.

APMIS. 2003 Oct;111(10):978-84.

PMID:
14616551
7.

Immunohistochemical localization of vitamin B12 R-binder in salivary gland tumors. Implications for cell differentiation.

Ogawa K, Ogawa O, Koshiba M, Sugiyama T, Wakatsuki Y, Kudo H, Kim YC, Nakashima Y, Yamabe H.

Pathol Res Pract. 1990 Dec;186(6):751-8.

PMID:
2084638
8.

Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics.

Pinto A, Nosé V, Rojas C, Fan YS, Gomez-Fernandez C.

Mod Pathol. 2014 Jan;27(1):30-7. doi: 10.1038/modpathol.2013.84. Epub 2013 Jun 28. Erratum in: Mod Pathol. 2014 Jun;27(6):918.

9.

Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.

Andreadis D, Epivatianos A, Mireas G, Nomikos A, Poulopoulos A, Yiotakis J, Barbatis C.

J Laryngol Otol. 2006 Apr;120(4):298-304.

PMID:
16623973
10.

Low-grade salivary duct carcinoma: description of 16 cases.

Brandwein-Gensler M, Hille J, Wang BY, Urken M, Gordon R, Wang LJ, Simpson JR, Simpson RH, Gnepp DR.

Am J Surg Pathol. 2004 Aug;28(8):1040-4.

PMID:
15252310
12.

The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.

Prasad AR, Savera AT, Gown AM, Zarbo RJ.

Arch Pathol Lab Med. 1999 Sep;123(9):801-6.

PMID:
10458827
13.

Hybrid tumors or salivary gland tumors sharing common differentiation pathways? Reexamining adenoid cystic and epithelial-myoepithelial carcinomas.

Grenko RT, Abendroth CS, Davis AT, Levin RJ, Dardick I.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Aug;86(2):188-95.

PMID:
9720095
14.
15.

Immunohistochemical evaluation of the Ca(2+)-binding S-100 proteins S-100A1, S-100A2, S-100A4, S-100A6 and S-100B in salivary gland tumors.

Huang JW, Ming Z, Shrestha P, Mori M, Ilg E, Schäfer BW, Heizmann CW.

J Oral Pathol Med. 1996 Nov;25(10):547-55.

PMID:
8986967
16.
17.

Mucin-rich variant of salivary duct carcinoma: a clinicopathologic and immunohistochemical study of four cases.

Simpson RH, Prasad AR, Lewis JE, Skálová A, David L.

Am J Surg Pathol. 2003 Aug;27(8):1070-9.

PMID:
12883239
18.

Expression of the adenocarcinoma-related antigen recognized by monoclonal antibody 44-3A6 in salivary gland neoplasias.

Bentz BG, Haines GK 3rd, vonSchlegell AS, Elseth KM, Hanson DG, Radosevich JA.

Otolaryngol Head Neck Surg. 1998 May;118(5):603-9.

PMID:
9591857
19.

Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy.

Liu G, Zheng H, Zhang Z, Wu Z, Xiong H, Li J, Song L.

BMC Cancer. 2010 Sep 16;10:495. doi: 10.1186/1471-2407-10-495.

20.

Iron-binding proteins in adenoid cystic carcinoma of salivary glands: an immunohistochemical study.

Takahashi H, Fujita S, Tsuda N, Tezuka F, Okabe H.

Tohoku J Exp Med. 1991 Jan;163(1):1-16.

Supplemental Content

Support Center